{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:48Z","timestamp":1792014408674,"version":"4.4.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>In the Northeast US, respiratory viruses such as influenza and respiratory syncytial virus (RSV), which were largely suppressed by COVID-19-related social distancing, made an unprecedented resurgence during 2022, leading to a substantial rise in viral co-infections. However, the relative rates of co-infection with seasonal respiratory viruses over this period have not been assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here we reviewed multiplex respiratory viral PCR data (BioFire FilmArray\u2122 Respiratory Panel v2.1 [RPP]) from patients with respiratory symptoms presenting to our medical center in New York City to assess co-infection rates of respiratory viruses, which were baselined to total rates of infection for each virus. We examined trends in monthly RPP data from adults and children during November 2021 through December 2022 to capture the full seasonal dynamics of respiratory viruses across periods of low and high prevalence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 50,022 RPPs performed for 34,610 patients, 44% were positive for at least one target, and 67% of these were from children. The overwhelming majority of co-infections (93%) were seen among children, for whom 21% of positive RPPs had two or more viruses detected, as compared to just 4% in adults. Relative to children for whom RPPs were ordered, children with co-infections were younger (3.0 vs 4.5 years) and more likely to be seen in the ED or outpatient settings than inpatient and ICU settings. In children, most viral co-infections were found at significantly reduced rates relative to that expected from the incidence of each virus, especially those involving SARS-CoV-2 and influenza. SARS-CoV-2 positive children had an 85%, 65% and 58% reduced rate of co-infection with influenza, RSV, and Rhino\/enteroviruses, respectively, after compensating for the incidence of infection with each virus (p&amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our results demonstrate that most respiratory viruses peaked in different months and present in co-infections less than would be expected based on overall rates of infection, suggesting a viral exclusionary effect between most seasonal respiratory viruses, including SARS-CoV-2, influenza and RSV. We also demonstrate the significant burden of respiratory viral co-infections among children. Further work is necessary to understand what predisposes certain patients for viral co-infection despite this exclusionary effect.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1208235","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:36:55Z","timestamp":1686721015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV"],"prefix":"10.3389","volume":"13","author":[{"given":"Maxwell D.","family":"Weidmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fann","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.15585\/mmwr.mm7150a4","article-title":"Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents Aged<18 years who were hospitalized or died with influenza - united states, 2021-22 influenza season","volume":"71","author":"Adams","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10070809","article-title":"Coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2: a systematic review and meta-analysis","volume":"10","author":"Alhumaid","year":"2021","journal-title":"Pathogens"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7110380","article-title":"Global coinfections with bacteria, fungi, and respiratory viruses in children with SARS-CoV-2: a systematic review and meta-analysis","volume":"7","author":"Alhumaid","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/00365548.2014.951681","article-title":"Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection","volume":"46","author":"Andersson","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112734","article-title":"Distribution of viral respiratory infections during the COVID-19 pandemic using the FilmArray respiratory panel","volume":"10","author":"Chen","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/S0140-6736(22)00484-6","article-title":"Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.jcvp.2021.100036","article-title":"Co-Infection of SARS-CoV-2 and influenza viruses: a systematic review and meta-analysis","volume":"1","author":"Dao","year":"2021","journal-title":"J. Clin. Virol. Plus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00196","article-title":"Multiplex platforms for the identification of respiratory pathogens: are they useful in pediatric clinical practice","volume":"9","author":"Esposito","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciw494","article-title":"Multiplexed molecular diagnostics for respiratory, gastrointestinal, and central nervous system infections","volume":"63","author":"Hanson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/cid\/ciaa508","article-title":"Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's diagnostics committee","volume":"71","author":"Hanson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12879-022-07089-9","article-title":"Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus","volume":"22","author":"Hedberg","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1186\/s12889-022-13555-5","article-title":"Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe","volume":"22","author":"Horemheb-Rubio","year":"2022","journal-title":"BMC Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/s41598-021-83642-x","article-title":"Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"21259","DOI":"10.1038\/s41598-021-00809-2","article-title":"Co-Infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters","volume":"11","author":"Kinoshita","year":"2021","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2365","article-title":"Respiratory viral co-infections in patients with COVID-19 and associated outcomes: a systematic review and meta-analysis","volume":"33","author":"Krumbein","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"B16","unstructured":"WHO COVID-19 dashboard2020"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcv.2018.12.005","article-title":"Human adenovirus in nasopharyngeal and blood samples from children with and without respiratory tract infections","volume":"111","author":"Schjelderup Nilsen","year":"2019","journal-title":"J. Clin. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0016321","DOI":"10.1128\/Spectrum.00163-21","article-title":"Coinfections with other respiratory pathogens among patients with COVID-19","volume":"9","author":"Sreenath","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"ofab618","DOI":"10.1093\/ofid\/ofab618","article-title":"Circulation of non-SARS-CoV-2 respiratory pathogens and coinfection with SARS-CoV-2 amid the COVID-19 pandemic","volume":"9","author":"Uhteg","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15585\/mmwr.mm705152a3","article-title":"Characteristics and clinical outcomes of children and adolescents Aged<18 years hospitalized with COVID-19 - six hospitals, united states, July-august 2021","volume":"70","author":"Wanga","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12887-022-03625-3","article-title":"Molecular epidemiology of human adenoviruses in children with and without respiratory symptoms: preliminary findings from a case-control study","volume":"22","author":"Zadheidar","year":"2022","journal-title":"BMC Pediatr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1208235\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:36:58Z","timestamp":1686721018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1208235\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":21,"alternative-id":["10.3389\/fcimb.2023.1208235"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1208235","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"article-number":"1208235"}}